IAP binding compounds

Details for Australian Patent Application No. 2005274937 (hide)

International Classifications

Event Publications

1 February 2007 PCT application entered the National Phase

PCT publication WO2006/020060 Priority application(s): WO2006/020060

23 June 2011 Amendment Made

The nature of the amendment is: Amend the priority details to read 60/588,050 15 Jul 2004 US and 60/692,111 20 Jun 2005 US 2005274937 Tetralogic Pharmaceuticals Corporation The nature of the amendment is: Amend the name of the inventor to read Laporte, Matthew G.; Rippin, Susan R.; Deng, Yijun; Condon, Stephen M. and McKinlay, Mark A. 2006

18 August 2011 Application Accepted

Published as AU-B-2005274937

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.